{"id":16199,"date":"2018-04-23T23:36:52","date_gmt":"2018-04-23T23:36:52","guid":{"rendered":"http:\/\/thepatientinvestor.com\/?p=16199"},"modified":"2018-04-23T23:56:32","modified_gmt":"2018-04-23T23:56:32","slug":"bob-doll-first-quarter-corporate-earnings-highly-impressive","status":"publish","type":"post","link":"https:\/\/thepatientinvestor.com\/index.php\/2018\/04\/23\/bob-doll-first-quarter-corporate-earnings-highly-impressive\/","title":{"rendered":"Bob Doll: First quarter corporate earnings highly impressive"},"content":{"rendered":"

\"Bob<\/p>\n

Bob Doll reports positive first quarter results so far in his weekly newsletter<\/a>:<\/p>\n

First quarter corporate earnings have been highly impressive. With approximately 20% of companies reporting, 81% have exceeded expectations by an average of 6.4%2<\/sup>. This compares to an average beat of 4.7% over the last three years, which underlies the strength of this quarter2<\/sup>. Much of the strength has come from reduced tax burdens: Earnings-per-share is on track to grow 23%, but would only be 16% were it not for the effects of lower taxes2<\/sup>.<\/p><\/blockquote>\n

Prices tend to follow earnings and a solid reporting season would likely see stocks posting new highs after the recent correction.<\/p>\n

2<\/sup> Data from Credit Suisse.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

Bob Doll reports positive first quarter results so far in his weekly newsletter: First quarter corporate earnings have been highly impressive. With approximately 20% of companies reporting, 81% have exceeded expectations by an average of 6.4%2. This compares to an average beat of 4.7% over the last three years, which underlies the strength of this … <\/p>\n

Continue reading “Bob Doll: First quarter corporate earnings highly impressive”<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_mo_disable_npp":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[48,34],"tags":[455,1154,3336],"class_list":["post-16199","post","type-post","status-publish","format-standard","hentry","category-earnings-dividends","category-us-canada-countries-regions","tag-bob-doll","tag-earnings","tag-tax-cuts"],"yoast_head":"\nBob Doll: First quarter corporate earnings highly impressive - the patient investor<\/title>\n<meta name=\"robots\" content=\"noindex, follow\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bob Doll: First quarter corporate earnings highly impressive - the patient investor\" \/>\n<meta property=\"og:description\" content=\"Bob Doll reports positive first quarter results so far in his weekly newsletter: First quarter corporate earnings have been highly impressive. With approximately 20% of companies reporting, 81% have exceeded expectations by an average of 6.4%2. This compares to an average beat of 4.7% over the last three years, which underlies the strength of this … Continue reading "Bob Doll: First quarter corporate earnings highly impressive"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/thepatientinvestor.com\/index.php\/2018\/04\/23\/bob-doll-first-quarter-corporate-earnings-highly-impressive\/\" \/>\n<meta property=\"og:site_name\" content=\"the patient investor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61572934660810\" \/>\n<meta property=\"article:author\" content=\"https:\/\/facebook.com\/people\/The-Patient-Investor\/61572934660810\/\" \/>\n<meta property=\"article:published_time\" content=\"2018-04-23T23:36:52+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-04-23T23:56:32+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/static.incrediblecharts.com\/images\/2018\/bobdoll.jpg\" \/>\n<meta name=\"author\" content=\"Colin Twiggs\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Colin Twiggs\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2018\/04\/23\/bob-doll-first-quarter-corporate-earnings-highly-impressive\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2018\/04\/23\/bob-doll-first-quarter-corporate-earnings-highly-impressive\/\"},\"author\":{\"name\":\"Colin Twiggs\",\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/person\/d42b18d516a80149d739845749ac6454\"},\"headline\":\"Bob Doll: First quarter corporate earnings highly impressive\",\"datePublished\":\"2018-04-23T23:36:52+00:00\",\"dateModified\":\"2018-04-23T23:56:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2018\/04\/23\/bob-doll-first-quarter-corporate-earnings-highly-impressive\/\"},\"wordCount\":114,\"publisher\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2018\/04\/23\/bob-doll-first-quarter-corporate-earnings-highly-impressive\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.incrediblecharts.com\/images\/2018\/bobdoll.jpg\",\"keywords\":[\"Bob Doll\",\"earnings\",\"tax cuts\"],\"articleSection\":[\"Earnings & Dividends\",\"US & Canada\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2018\/04\/23\/bob-doll-first-quarter-corporate-earnings-highly-impressive\/\",\"url\":\"https:\/\/thepatientinvestor.com\/index.php\/2018\/04\/23\/bob-doll-first-quarter-corporate-earnings-highly-impressive\/\",\"name\":\"Bob Doll: First quarter corporate earnings highly impressive - the patient investor\",\"isPartOf\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2018\/04\/23\/bob-doll-first-quarter-corporate-earnings-highly-impressive\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2018\/04\/23\/bob-doll-first-quarter-corporate-earnings-highly-impressive\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.incrediblecharts.com\/images\/2018\/bobdoll.jpg\",\"datePublished\":\"2018-04-23T23:36:52+00:00\",\"dateModified\":\"2018-04-23T23:56:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2018\/04\/23\/bob-doll-first-quarter-corporate-earnings-highly-impressive\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/thepatientinvestor.com\/index.php\/2018\/04\/23\/bob-doll-first-quarter-corporate-earnings-highly-impressive\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2018\/04\/23\/bob-doll-first-quarter-corporate-earnings-highly-impressive\/#primaryimage\",\"url\":\"https:\/\/www.incrediblecharts.com\/images\/2018\/bobdoll.jpg\",\"contentUrl\":\"https:\/\/www.incrediblecharts.com\/images\/2018\/bobdoll.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2018\/04\/23\/bob-doll-first-quarter-corporate-earnings-highly-impressive\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/thepatientinvestor.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bob Doll: First quarter corporate earnings highly impressive\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/thepatientinvestor.com\/#website\",\"url\":\"https:\/\/thepatientinvestor.com\/\",\"name\":\"The Patient Investor\",\"description\":\"Smart. Strategic. Unfiltered. \",\"publisher\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/thepatientinvestor.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/thepatientinvestor.com\/#organization\",\"name\":\"The Patient Investor Pty Ltd\",\"url\":\"https:\/\/thepatientinvestor.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1\",\"contentUrl\":\"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1\",\"width\":250,\"height\":250,\"caption\":\"The Patient Investor Pty Ltd\"},\"image\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/profile.php?id=61572934660810\",\"https:\/\/www.instagram.com\/colin_thepatientinvestor\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/person\/d42b18d516a80149d739845749ac6454\",\"name\":\"Colin Twiggs\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g\",\"caption\":\"Colin Twiggs\"},\"description\":\"Colin Twiggs is a former investment banker with almost 40 years of experience in financial markets. He co-founded Incredible Charts and writes the popular Trading Diary and Patient Investor newsletters. Using a top-down approach, Colin identifies key macro trends in the global economy before evaluating selected opportunities using a combination of fundamental and technical analysis. Focusing on interest rates and financial market liquidity as primary drivers of the economic cycle, he warned of the 2008\/2009 and 2020 bear markets well ahead of actual events. He founded PVT Capital (AFSL No. 546090) in May 2023, which offers investment strategy and advice to wholesale clients.\",\"sameAs\":[\"https:\/\/facebook.com\/people\/The-Patient-Investor\/61572934660810\/\",\"https:\/\/www.instagram.com\/colin_thepatientinvestor\",\"https:\/\/au.linkedin.com\/in\/colintwiggs\"],\"url\":\"https:\/\/thepatientinvestor.com\/index.php\/author\/investor\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bob Doll: First quarter corporate earnings highly impressive - the patient investor","robots":{"index":"noindex","follow":"follow"},"og_locale":"en_US","og_type":"article","og_title":"Bob Doll: First quarter corporate earnings highly impressive - the patient investor","og_description":"Bob Doll reports positive first quarter results so far in his weekly newsletter: First quarter corporate earnings have been highly impressive. With approximately 20% of companies reporting, 81% have exceeded expectations by an average of 6.4%2. This compares to an average beat of 4.7% over the last three years, which underlies the strength of this … Continue reading \"Bob Doll: First quarter corporate earnings highly impressive\"","og_url":"https:\/\/thepatientinvestor.com\/index.php\/2018\/04\/23\/bob-doll-first-quarter-corporate-earnings-highly-impressive\/","og_site_name":"the patient investor","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61572934660810","article_author":"https:\/\/facebook.com\/people\/The-Patient-Investor\/61572934660810\/","article_published_time":"2018-04-23T23:36:52+00:00","article_modified_time":"2018-04-23T23:56:32+00:00","og_image":[{"url":"http:\/\/static.incrediblecharts.com\/images\/2018\/bobdoll.jpg","type":"","width":"","height":""}],"author":"Colin Twiggs","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Colin Twiggs","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/thepatientinvestor.com\/index.php\/2018\/04\/23\/bob-doll-first-quarter-corporate-earnings-highly-impressive\/#article","isPartOf":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2018\/04\/23\/bob-doll-first-quarter-corporate-earnings-highly-impressive\/"},"author":{"name":"Colin Twiggs","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/person\/d42b18d516a80149d739845749ac6454"},"headline":"Bob Doll: First quarter corporate earnings highly impressive","datePublished":"2018-04-23T23:36:52+00:00","dateModified":"2018-04-23T23:56:32+00:00","mainEntityOfPage":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2018\/04\/23\/bob-doll-first-quarter-corporate-earnings-highly-impressive\/"},"wordCount":114,"publisher":{"@id":"https:\/\/thepatientinvestor.com\/#organization"},"image":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2018\/04\/23\/bob-doll-first-quarter-corporate-earnings-highly-impressive\/#primaryimage"},"thumbnailUrl":"https:\/\/www.incrediblecharts.com\/images\/2018\/bobdoll.jpg","keywords":["Bob Doll","earnings","tax cuts"],"articleSection":["Earnings & Dividends","US & Canada"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/thepatientinvestor.com\/index.php\/2018\/04\/23\/bob-doll-first-quarter-corporate-earnings-highly-impressive\/","url":"https:\/\/thepatientinvestor.com\/index.php\/2018\/04\/23\/bob-doll-first-quarter-corporate-earnings-highly-impressive\/","name":"Bob Doll: First quarter corporate earnings highly impressive - the patient investor","isPartOf":{"@id":"https:\/\/thepatientinvestor.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2018\/04\/23\/bob-doll-first-quarter-corporate-earnings-highly-impressive\/#primaryimage"},"image":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2018\/04\/23\/bob-doll-first-quarter-corporate-earnings-highly-impressive\/#primaryimage"},"thumbnailUrl":"https:\/\/www.incrediblecharts.com\/images\/2018\/bobdoll.jpg","datePublished":"2018-04-23T23:36:52+00:00","dateModified":"2018-04-23T23:56:32+00:00","breadcrumb":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2018\/04\/23\/bob-doll-first-quarter-corporate-earnings-highly-impressive\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/thepatientinvestor.com\/index.php\/2018\/04\/23\/bob-doll-first-quarter-corporate-earnings-highly-impressive\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepatientinvestor.com\/index.php\/2018\/04\/23\/bob-doll-first-quarter-corporate-earnings-highly-impressive\/#primaryimage","url":"https:\/\/www.incrediblecharts.com\/images\/2018\/bobdoll.jpg","contentUrl":"https:\/\/www.incrediblecharts.com\/images\/2018\/bobdoll.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/thepatientinvestor.com\/index.php\/2018\/04\/23\/bob-doll-first-quarter-corporate-earnings-highly-impressive\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/thepatientinvestor.com\/"},{"@type":"ListItem","position":2,"name":"Bob Doll: First quarter corporate earnings highly impressive"}]},{"@type":"WebSite","@id":"https:\/\/thepatientinvestor.com\/#website","url":"https:\/\/thepatientinvestor.com\/","name":"The Patient Investor","description":"Smart. Strategic. Unfiltered. ","publisher":{"@id":"https:\/\/thepatientinvestor.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/thepatientinvestor.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/thepatientinvestor.com\/#organization","name":"The Patient Investor Pty Ltd","url":"https:\/\/thepatientinvestor.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1","contentUrl":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1","width":250,"height":250,"caption":"The Patient Investor Pty Ltd"},"image":{"@id":"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61572934660810","https:\/\/www.instagram.com\/colin_thepatientinvestor"]},{"@type":"Person","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/person\/d42b18d516a80149d739845749ac6454","name":"Colin Twiggs","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g","caption":"Colin Twiggs"},"description":"Colin Twiggs is a former investment banker with almost 40 years of experience in financial markets. He co-founded Incredible Charts and writes the popular Trading Diary and Patient Investor newsletters. Using a top-down approach, Colin identifies key macro trends in the global economy before evaluating selected opportunities using a combination of fundamental and technical analysis. Focusing on interest rates and financial market liquidity as primary drivers of the economic cycle, he warned of the 2008\/2009 and 2020 bear markets well ahead of actual events. He founded PVT Capital (AFSL No. 546090) in May 2023, which offers investment strategy and advice to wholesale clients.","sameAs":["https:\/\/facebook.com\/people\/The-Patient-Investor\/61572934660810\/","https:\/\/www.instagram.com\/colin_thepatientinvestor","https:\/\/au.linkedin.com\/in\/colintwiggs"],"url":"https:\/\/thepatientinvestor.com\/index.php\/author\/investor\/"}]}},"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p9tQ4n-4dh","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":14360,"url":"https:\/\/thepatientinvestor.com\/index.php\/2016\/10\/17\/weekly-investment-commentary-from-bob-doll-nuveen\/","url_meta":{"origin":16199,"position":0},"title":"Weekly Investment Commentary from Bob Doll | Nuveen","author":"ColinTwiggs","date":"October 17, 2016","format":false,"excerpt":"From Bob Doll: Equities may struggle until corporate earnings improve. For the past 18 months, equities have been able to make modest gains despite declining corporate profits. This has largely been due to highly accommodative monetary policy and central banks\u2019 willingness to engage in new easing measures. Additionally, investors have\u2026","rel":"","context":"In "Stock Markets"","block_context":{"text":"Stock Markets","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/stock-markets\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":16252,"url":"https:\/\/thepatientinvestor.com\/index.php\/2018\/05\/07\/bob-doll-first-quarter-earnings-continue-to-impress\/","url_meta":{"origin":16199,"position":1},"title":"Bob Doll: First quarter earnings continue to impress","author":"Colin Twiggs","date":"May 7, 2018","format":false,"excerpt":"More positive news on earnings from Bob Doll's weekly newsletter: .....2. First quarter earnings results continue to impress, helped by tax cuts. With 85% of companies reporting, earnings are ahead of expectations by an average of 7.3%.1 Earnings-per-share growth is on track for 25%.1 Were it not for the effects\u2026","rel":"","context":"In "Earnings & Dividends"","block_context":{"text":"Earnings & Dividends","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/investing\/earnings-dividends\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":14196,"url":"https:\/\/thepatientinvestor.com\/index.php\/2016\/09\/19\/bob-doll-equities-appear-more-attractive-than-other-asset-classes-nuveen\/","url_meta":{"origin":16199,"position":2},"title":"Bob Doll: Equities Appear More Attractive than Other Asset Classes | Nuveen","author":"ColinTwiggs","date":"September 19, 2016","format":false,"excerpt":"From Bob Doll's weekly newsletter: The strong patch of summer U.S. economic data may have ended. Following weak Institute for Supply Management readings in previous weeks, August retail sales declined 0.3%. This marks the first pullback since March, and bears watching for a broader downtrend into September..... Corporate earnings expectations\u2026","rel":"","context":"In "Economy"","block_context":{"text":"Economy","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/economy\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":16720,"url":"https:\/\/thepatientinvestor.com\/index.php\/2018\/07\/24\/strong-earnings-results-are-from-revenue-gains-bob-doll\/","url_meta":{"origin":16199,"position":3},"title":"Strong earnings results are from revenue gains | Bob Doll","author":"Colin Twiggs","date":"July 24, 2018","format":"quote","excerpt":"\"Strong earnings results are coming more from revenue gains than bottom-line margins. Since 2010, 90% of positive earnings surprises have come from margins. This quarter, 75% of surprises are from better revenues. This is a healthy sign for future earnings results, and hence for stock prices.\" From Bob Doll at\u2026","rel":"","context":"In "Earnings & Dividends"","block_context":{"text":"Earnings & Dividends","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/investing\/earnings-dividends\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":14399,"url":"https:\/\/thepatientinvestor.com\/index.php\/2016\/10\/24\/bob-dolls-bullet-points\/","url_meta":{"origin":16199,"position":4},"title":"Bob Doll’s bullet points","author":"ColinTwiggs","date":"October 24, 2016","format":false,"excerpt":"From Bob Doll's weekly commentary for Nuveen Investments: Third-quarter earnings started strong. Should this persist, it may mark the end of the earnings recession. It looks likely that Hillary Clinton will win the presidency while the House remains in GOP hands. Equity markets face near-term pressures, but the economic and\u2026","rel":"","context":"In "Stock Markets"","block_context":{"text":"Stock Markets","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/stock-markets\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":15370,"url":"https:\/\/thepatientinvestor.com\/index.php\/2017\/05\/30\/weekly-investment-commentary-from-bob-doll-nuveen-2\/","url_meta":{"origin":16199,"position":5},"title":"Weekly Investment Commentary from Bob Doll | Nuveen","author":"ColinTwiggs","date":"May 30, 2017","format":false,"excerpt":"Key points from Bob Doll's weekly investment summary: We believe U.S. economic growth should rebound in the second quarter and corporate earnings will remain solid. Investors remain uneasy about global macro conditions, but we believe the backdrop remains supportive for equities. We may be seeing a transition in global equity\u2026","rel":"","context":"In "Stock Markets"","block_context":{"text":"Stock Markets","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/stock-markets\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"_links":{"self":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts\/16199","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/comments?post=16199"}],"version-history":[{"count":4,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts\/16199\/revisions"}],"predecessor-version":[{"id":16203,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts\/16199\/revisions\/16203"}],"wp:attachment":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/media?parent=16199"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/categories?post=16199"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/tags?post=16199"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}